Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LANSOPRAZOLE Cause Benign prostatic hyperplasia? 23 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Benign prostatic hyperplasia have been filed in association with LANSOPRAZOLE (Lansoprazole). This represents 0.0% of all adverse event reports for LANSOPRAZOLE.

23
Reports of Benign prostatic hyperplasia with LANSOPRAZOLE
0.0%
of all LANSOPRAZOLE reports
20
Deaths
22
Hospitalizations

How Dangerous Is Benign prostatic hyperplasia From LANSOPRAZOLE?

Of the 23 reports, 20 (87.0%) resulted in death, 22 (95.7%) required hospitalization, and 19 (82.6%) were considered life-threatening.

Is Benign prostatic hyperplasia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LANSOPRAZOLE. However, 23 reports have been filed with the FAERS database.

What Other Side Effects Does LANSOPRAZOLE Cause?

Chronic kidney disease (32,517) Acute kidney injury (16,359) Renal failure (12,509) End stage renal disease (9,734) Renal injury (9,383) Tubulointerstitial nephritis (3,860) Death (2,517) Gastrooesophageal reflux disease (2,482) Off label use (2,183) Nephrogenic anaemia (2,162)

What Other Drugs Cause Benign prostatic hyperplasia?

TADALAFIL (596) TAMSULOSIN (304) FINASTERIDE (266) PANTOPRAZOLE (261) PREDNISONE (257) ALBUTEROL (254) ASPIRIN (243) TIOTROPIUM (235) RAMIPRIL (193) AMLODIPINE (179)

Which LANSOPRAZOLE Alternatives Have Lower Benign prostatic hyperplasia Risk?

LANSOPRAZOLE vs LANTHANUM LANSOPRAZOLE vs LANTUS LANSOPRAZOLE vs LANTUS SOLOSTAR LANSOPRAZOLE vs LAPATINIB LANSOPRAZOLE vs LAPATINIB DITOSYLATE

Related Pages

LANSOPRAZOLE Full Profile All Benign prostatic hyperplasia Reports All Drugs Causing Benign prostatic hyperplasia LANSOPRAZOLE Demographics